| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.45(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $17.2 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
147,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,195,450 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simmons Jeffrey N |
Presiident, CEO & Director |
• • – |
2019-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
264,718 |
394,256 |
|
- |
|
| Hoover R David |
Director |
– • – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
I/I |
920 |
920 |
2.02 |
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
1,227 |
12,741 |
2.66 |
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
2,021 |
14,000 |
2.66 |
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
1,227 |
13,924 |
2.66 |
- |
|
| Simmons Jeffrey N |
Presiident, CEO & Director |
• • – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
37,301 |
129,538 |
2.73 |
- |
|
| Kinard David S |
See Remarks |
• – – |
2019-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
7,977 |
22,569 |
2.66 |
- |
|
| Lilly Eli & Co |
10% Owner |
– – • |
2019-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(293,290,000) |
0 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,535 |
11,514 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
11,979 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,113 |
14,592 |
|
- |
|
| Lin Sarena S |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,136 |
33,115 |
|
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,181 |
22,906 |
|
- |
|
| Simmons Jeffrey N |
Presiident, CEO & Director |
• • – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
33,950 |
92,237 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,900 |
18,883 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
820 |
5,237 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,318 |
12,697 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2018-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,192 |
4,417 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2018-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,983 |
8,983 |
|
- |
|
| Kurzius Lawrence Erik |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,796 |
11,796 |
|
- |
|
| Hoover R David |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,796 |
11,796 |
|
- |
|
| Anand Kapila K |
Director |
– • – |
2018-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,796 |
2,996 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2018-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
7,379 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2018-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
7,979 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2018-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
9,479 |
|
- |
|
390 Records found
|
|
Page 15 of 16 |
|
|
0.21 (1.24%) 
